Australian Clinical Labs Converts Service Rights Into Shares
ACL: $3.20 +0.95% · MC: $619M
Australian Clinical Labs converted 31,368 service rights into ordinary shares, with the conversion completed between late October and early November. The shares were already quoted on ASX, and the company reported 186.5 million ordinary shares on issue following the conversion.

Comments